Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Ben Gruenstein Moderates Panel at ACI’s 3rd Annual Forum on Digital Assets

November 19, 2024

On November 18, 2024, Cravath partner Benjamin Gruenstein participated in the American Conference Institute’s 3rd Annual Forum on Digital Assets: Compliance, Enforcement & Regulatory Oversight, which was held from November 18‑19 in New York. The event convened government officials, crypto companies and legal and regulatory experts to address pressing developments in the regulation of digital assets. Ben moderated a panel entitled “What Keeps You Up at Night? Senior Executives Discuss Their Top Priorities and Post-Election Predictions,” during which panelists discussed their views on the current regulatory environment, how they are revisiting risk and their thoughts for the future of the industry.

Related Practices & Industries

  • Litigation
  • Investigations and Regulatory Enforcement
  • Blockchain, Cryptocurrency and Digital Assets
  • Fintech
  • Technology

Speakers

Photo
Name
Benjamin Gruenstein
Title
Litigation
Title
Partner
Email
bgruenstein@cravath.com
Phone
+1-212-474-1080
vCard
Download vCard

    Education

    • J.D., 1999, Harvard Law School
      magna cum laude
    • A.B., 1996, Harvard College
      Phi Beta Kappa, summa cum laude

    Admitted In

    • New York
    • District of Columbia

    Related News & Insights

    Deals & Cases

    July 09, 2024

    Silvergate’s Settlement Agreements with the Federal Reserve, California Department of Financial Protection and Innovation and Securities and Exchange Commission

    On July 1, 2024, Silvergate announced it has agreed to settlements with the Board of Governors of the Federal Reserve System (“Federal Reserve”), the California Department of Financial Protection and Innovation (“DFPI”) and the Securities and Exchange Commission (“SEC”). In a statement, Silvergate noted its decision to liquidate voluntarily and without government assistance in March 2023, and that, as of November 2023, all deposits had been repaid to banking customers, soon after which Silvergate ceased banking operations. The announced settlements, which facilitate the surrender of Silvergate’s bank charter, are part of the Bank’s continued orderly wind down and conclude investigations by the Federal Reserve, DFPI, and SEC. Cravath represented Silvergate in connection with the investigations, resulting settlements, and voluntary liquidation.

    Deals & Cases

    May 17, 2024

    Cravath’s Amicus Brief Supports Successful Dismissal of FTC Claims Against Welsh Carson

    On May 13, 2024, the U.S. District Court for the Southern District of Texas dismissed claims brought by the Federal Trade Commission (“FTC”) against private equity firm Welsh Carson relating to U.S. Anesthesia Partners’ (“USAP”) acquisition of anesthesiology practices in Texas, and other allegedly anticompetitive conduct. In a novel approach, the FTC had named both USAP and Welsh Carson, a minority investor, as defendants in the case. On behalf of Cravath client American Investment Council, Cravath submitted an amicus brief in support of Welsh Carson’s motion to dismiss.

    Deals & Cases

    February 22, 2024

    New York State Appellate Division Reverses Wrongful Criminal Conviction Resulting from Consolidated Indictments

    On February 13, 2024, the New York State Appellate Division, First Department, reversed the convictions of Tommy Davis, who was simultaneously prosecuted for two unrelated incidents involving firearms. Cravath represented Mr. Davis on a pro bono basis alongside co‑counsel at the Office of the Appellate Defender.

    Deals & Cases

    October 09, 2023

    Abiomed Defeats Motion to Dismiss Lawsuit Over Misappropriated Trade Secrets

    On September 22, 2023, the U.S. District Court for the District of Massachusetts ruled in favor of Cravath clients Abiomed, Inc. and Abiomed Europe GmbH (together, “Abiomed”), denying a motion to dismiss litigation brought by Abiomed against German defendants Enmodes GmbH and its CEO Tim Kaufmann.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.